QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or "the Company") today announced the successful closing ...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

Core News & Articles

MBX: 46% | MBX Biosciences shares are trading higher after the company announced that it will provide topline results from its ...

Core News & Articles

LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Farad...

 reported-on-september-16th-qualigen-therapeutics-files-to-sell-up-to-321m-shares-of-common-stock-for-holders

-SEC Filing

 qualigen-therapeutics-provides-update-on-nasdaq-communications-and-continued-listing-status-company-is-making-every-effort-to-maintain-its-current-nasdaq-listing-and-will-continue-to-take-all-necessary-actions-toward-that-goal-however-there-can-be-no-assurance-that-the-company-will-be-able-to-maintain-compliance-with-nasdaqs-continued-listing-requirement

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) (the "Company") received ...

 qualigen-announces-45m-private-placement-of-4500-shares-of-series-a-3-preferred-stock-convertible-into-161m-common-shares-at-280-each

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on dev...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION